Wells Fargo & Company Ocular Therapeutix, Inc Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Wells Fargo & Company holds 36,039 shares of OCUL stock, worth $246,506. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,039

Previous 22,203 62.32%

Holding current value

$246,506

Previous $99,000 230.3%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$3.85 - $10.93 $53,268 - $151,227	13,836 Added 62.32%	36,039 $327,000
Q4 2023 Feb 09, 2024	BUY	$2.08 - $4.52 $10,562 - $22,952	5,078 Added 29.65%	22,203 $99,000
Q3 2023 Nov 13, 2023	SELL	$3.14 - $5.04 $54,598 - $87,635	-17,388 Reduced 50.38%	17,125 $53,000
Q2 2023 Aug 15, 2023	BUY	$4.6 - $7.64 $76,930 - $127,771	16,724 Added 94.01%	34,513 $178,000
Q1 2023 May 12, 2023	BUY	$2.79 - $6.27 $44,190 - $99,310	15,839 Added 812.26%	17,789 $93,000

Q4 2022 Feb 13, 2023	SELL	$2.61 - $4.41 $11,906 - $20,118	-4,562 Reduced 70.06%	1,950 $5,000
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $2,474 - $3,932	-605 Reduced 8.5%	6,512 $27,000
Q2 2022 Aug 12, 2022	SELL	$3.01 - $5.22 $27,400 - $47,517	-9,103 Reduced 56.12%	7,117 $29,000
Q1 2022 May 16, 2022	SELL	$4.83 - $7.35 $124,691 - $189,747	-25,816 Reduced 61.41%	16,220 $80,000
Q4 2021 Feb 14, 2022	SELL	$6.16 - $12.07 $89,012 - $174,411	-14,450 Reduced 25.58%	42,036 $292,000
Q3 2021 Nov 15, 2021	SELL	$9.7 - $14.34 $153,502 - $226,930	-15,825 Reduced 21.88%	56,486 $565,000
Q2 2021 Aug 16, 2021	SELL	$13.43 - $19.16 $6.22 Million - $8.87 Million	-463,021 Reduced 86.49%	72,311 $1.03 Million
Q1 2021 May 13, 2021	BUY	$15.82 - $22.11 $3.68 Million - $5.14 Million	232,689 Added 76.89%	535,332 $8.79 Million
Q4 2020 Feb 09, 2021	BUY	$7.91 - $22.95 $1.07 Million - $3.12 Million	135,832 Added 81.43%	302,643 $6.26 Million
Q3 2020 Nov 05, 2020	BUY	$7.36 - $9.87 $725,784 - $973,300	98,612 Added 144.59%	166,811 $1.27 Million
Q2 2020 Aug 13, 2020	BUY	$4.67 - $8.95 $71,315 - $136,675	15,271 Added 28.85%	68,199 $568,000
Q1 2020 May 14, 2020	BUY	$3.95 - $7.4 $209,065 - $391,667	52,928 New	52,928 $262,000

Others Institutions Holding OCUL

# of Institutions

148

Shares Held

123M

Call Options Held

185K

Put Options Held

507K

View Full List

About OCULAR THERAPEUTIX, INC

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

More about OCUL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Ocular Therapeutix, Inc Transaction History